Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Earnhart & Associates

Earnhart & Associates, Inc. is a healthcare consulting firm that specializes in ambulatory care services. We have been providing hi-quality, cost-effective consulting and management services for over 17 years


Contact Details:
1000 Westbank Drive Suite 5B
Austin
Texas
78746
United States of America
Tel:512.320.8580
Fax:512.320.8581
Email:
WWW:

www.earnhart.com/




Loading...

Recent Publications by Earnhart & Associates:

An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
Lyme disease is the most common vector-borne disease in North America and...
21st June, 2008
Department of Microbiology and Immunology, Virginia Commonwealth Hum Vaccin. 2007 Nov-Dec;3(6):281-9. Epub 2007 Jul 2.
OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.
Using available Borrelia outer surface protein C (OspC) sequences, a...
15th June, 2007
Department of Microbiology and Immunology, Center for the Study of Clin Vaccine Immunol. 2007 May;14(5):628-34. Epub 2007 Mar 14.
DOI Direct Link
Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
There is currently no Lyme disease vaccine commercially available for use...
1st June, 2007
Department of Microbiology and Immunology, Medical College of Virginia at Vaccine. 2007 Apr 30;25(17):3419-27. Epub 2007 Jan 17.
DOI Direct Link
Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
Lyme disease is the most common arthropod-borne disease in North America...
28th February, 2007
Department of Microbiology and Immunology, Medical College of Virginia at Vaccine. 2007 Jan 5;25(3):466-80. Epub 2006 Aug 8.
DOI Direct Link
Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
The OspC protein of Borrelia burgdorferi is an immunodominant antigen....
9th January, 2007
Department of Microbiology and Immunology, Medical College of Virginia at Clin Vaccine Immunol. 2006 Oct;13(10):1162-5.
DOI Direct Link

View more Earnhart & Associates research publications.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 240 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in Austin

Search for more companies in Texas



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Earnhart & Associates

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.